311 related articles for article (PubMed ID: 28623857)
21. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
[TBL] [Abstract][Full Text] [Related]
22. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
Lavoie Smith EM; Li L; Chiang C; Thomas K; Hutchinson RJ; Wells EM; Ho RH; Skiles J; Chakraborty A; Bridges CM; Renbarger J
J Peripher Nerv Syst; 2015 Mar; 20(1):37-46. PubMed ID: 25977177
[TBL] [Abstract][Full Text] [Related]
23. Vincristine-induced vocal cord paresis and paralysis in children.
Zavala H; Roby BB; Day A; Bostrom B; Sidman J; Chinnadurai S
Int J Pediatr Otorhinolaryngol; 2019 Aug; 123():1-4. PubMed ID: 31048222
[TBL] [Abstract][Full Text] [Related]
24. Clinical and electrophysiological studies in vincristine induced neuropathy.
Pal PK
Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):323-30. PubMed ID: 10499201
[TBL] [Abstract][Full Text] [Related]
25. Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia.
Baker SK; Lipson DM
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e114-7. PubMed ID: 20216233
[TBL] [Abstract][Full Text] [Related]
26. Successful alternative treatment containing vindesine for acute lymphoblastic leukemia with Charcot-Marie-Tooth disease.
Ichikawa M; Suzuki D; Inamoto J; Ohshima J; Cho Y; Saitoh S; Kaneda M; Iguchi A; Ariga T
J Pediatr Hematol Oncol; 2012 Apr; 34(3):239-41. PubMed ID: 22246157
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of vincristine toxicity with concomitant fluconazole prophylaxis in children with acute lymphoblastic leukemia.
Teusink AC; Ragucci D; Shatat IF; Kalpatthi R
Pediatr Hematol Oncol; 2012 Feb; 29(1):62-7. PubMed ID: 22304011
[TBL] [Abstract][Full Text] [Related]
28. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia.
Reinders-Messelink HA; Van Weerden TW; Fock JM; Gidding CE; Vingerhoets HM; Schoemaker MM; Göeken LN; Bökkerink JP; Kamps WA
Eur J Paediatr Neurol; 2000; 4(5):225-33. PubMed ID: 11030069
[TBL] [Abstract][Full Text] [Related]
29. Vincristine-induced neuropathy: Atypical electrophysiological patterns in children.
Courtemanche H; Magot A; Ollivier Y; Rialland F; Leclair-Visonneau L; Fayet G; Camdessanché JP; Péréon Y
Muscle Nerve; 2015 Dec; 52(6):981-5. PubMed ID: 25758843
[TBL] [Abstract][Full Text] [Related]
30. Vincristine neurotoxicity in the presence of hereditary neuropathy.
Trobaugh-Lotrario AD; Smith AA; Odom LF
Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685
[No Abstract] [Full Text] [Related]
31. [A cohort study of vincristine-induced peripheral neuropathy in children].
Li C; Jin J; Huang J; Yang XY; Li Y; Yan YY; Yang C
Zhongguo Dang Dai Er Ke Za Zhi; 2023 May; 25(5):470-475. PubMed ID: 37272172
[TBL] [Abstract][Full Text] [Related]
32. Vincristine-induced vocal cord paralysis in an infant.
Anghelescu DL; De Armendi AJ; Thompson JW; Sillos EM; Pui CH; Sandlund JT
Paediatr Anaesth; 2002 Feb; 12(2):168-70. PubMed ID: 11882230
[TBL] [Abstract][Full Text] [Related]
33. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy.
Moudgil SS; Riggs JE
Ann Pharmacother; 2000 Oct; 34(10):1136-8. PubMed ID: 11054980
[TBL] [Abstract][Full Text] [Related]
34. Incidence of vincristine induced neurotoxicity in children with acute lymphoblastic leukemia and its correlation with nutritional deficiencies.
Dudeja S; Gupta S; Sharma S; Jain A; Sharma S; Jain P; Aneja S; Chandra J
Pediatr Hematol Oncol; 2019 Sep; 36(6):344-351. PubMed ID: 31514565
[TBL] [Abstract][Full Text] [Related]
35. Pyridoxine treatment of vincristine-induced cranial polyneuropathy in an adult patient with acute lymphocytic leukemia: Case report and review of the literature.
Ngamphaiboon N; Sweeney R; Wetzler M; Wang ES
Leuk Res; 2010 Aug; 34(8):e194-6. PubMed ID: 20167372
[No Abstract] [Full Text] [Related]
36. Switching to Bortezomib may Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia.
Joshi J; Tanner L; Gilchrist L; Bostrom B
J Pediatr Hematol Oncol; 2019 Aug; 41(6):457-462. PubMed ID: 31233464
[TBL] [Abstract][Full Text] [Related]
37. Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia.
Yang L; Yu L; Chen X; Hu Y; Wang B
Med Sci Monit; 2015 Jun; 21():1656-61. PubMed ID: 26050202
[TBL] [Abstract][Full Text] [Related]
38. Treatment of vincristine-induced ileus with metoclopramide: A case report.
Masoumi HT; Hadjibabaie M; Zarif-Yeganeh M; Khajeh B; Ghavamzadeh A
J Oncol Pharm Pract; 2019 Mar; 25(2):507-511. PubMed ID: 29224457
[TBL] [Abstract][Full Text] [Related]
39. Higher incidence of syndrome of inappropriate antidiuretic hormone secretion during induction chemotherapy of acute lymphoblastic leukemia in indian children.
Seetharam S; Thankamony P; Gopakumar KG; Krishna KMJ
Indian J Cancer; 2019; 56(4):320-324. PubMed ID: 31607700
[TBL] [Abstract][Full Text] [Related]
40. Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.
Li L; Sajdyk T; Smith EML; Chang CW; Li C; Ho RH; Hutchinson R; Wells E; Skiles JL; Winick N; Martin PL; Renbarger JL
Clin Pharmacol Ther; 2019 Jun; 105(6):1421-1428. PubMed ID: 30506673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
